Who is sponsoring NCT03546920?

NCT03546920 is sponsored by University of Colorado, Denver.

What drugs are being tested in NCT03546920?

Interventions in NCT03546920: ALIGN Intervention Phase.

What condition does NCT03546920 study?

NCT03546920 studies Advanced Medical Illness.

Is NCT03546920 still recruiting?

NCT03546920 is currently completed. Last updated 10 July 2019.

Last reviewed 2019-07-10 · How we verify

NCT03546920: ALIGN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Integrating Palliative Care Social Workers Into Sub-Acute Settings: A Feasibility Trial

Completed NA Last updated 10 July 2019

What this trial tests

NA trial testing ALIGN Intervention Phase in Advanced Medical Illness in 220 participants. Completed in 16 June 2019.

Timeline

8 January 2018

Primary endpoint
16 June 2019

16 June 2019

Quick facts

Lead sponsor	University of Colorado, Denver
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	supportive care
Enrollment	220
Start date	8 January 2018
Primary completion	16 June 2019
Estimated completion	16 June 2019
Sites	1 location across United States

Drugs / interventions tested

ALIGN Intervention Phase

Conditions studied

Advanced Medical Illness — all drugs for Advanced Medical Illness →

Sponsor

University of Colorado, Denver

Who can join

65 and older, any sex, with Advanced Medical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a feasibility trial utilizing a step wedge design of a social worker led palliative care intervention for 120 adult patients with advanced medical illness being cared for in a subacute nursing facility. Caregivers are also invited to participate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Colorado, Denver trials

Trials by the same sponsor.

NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03546920 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
Last refreshed: 10 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03546920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing